In the model of oral squamous cell carcinoma, Tołoczko-Iwaniuk demonstrated that celecoxib, a well-known inhibitor of COX-2, increased levels of POX/PRODH and, as a result, led to apoptosis [81]. The gene discussed is PRODH; the disease is oral cavity squamous cell carcinoma.